{'Year': '2011', 'Month': 'Feb'}
Pharmacoeconomic evaluation of warfarin pharmacogenomics.
the merit of applying pharmacogenomics in the induction phase of warfarin therapy for personalized dosing is controversial and highly dependent on its cost-effectiveness.